Skip to content

KEEL KEEL ATM Program issuances

ATM Program issuances at other companies

GTY
Getty RealtyGTY
$19.92M+80.9%
Red Cat Holdings, Inc. logo
Red Cat Holdings, Inc.RCAT
$0
Ameren logo
AmerenAEE
$1B+335%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$16.4M+50.7%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$11.63M
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$12.11M

Other financials

Income statement

See full
Revenue$37.0M-22.4%
Gross profit-$26.3M-9,631%
Operating income-$98.4M-182%
Net income-$145.4M-162%
EPS (diluted)-$0.24-118%

Balance sheet

See full
Cash & equivalents$357.3M+827%
Total debt$591.0M
Total equity$419.1M-36.6%
Total assets$1.1B

Cash flow

See full
Operating cash flow-$64.7M-243%
CapEx$10.3M-76.2%
Free cash flow-$75.0M-20.6%

Valuation

See full
Market cap$3.99B

Profitability

See full
Gross margin-7.9%-2.8pp
Operating margin-37.8%+2.0pp
Net margin-52%+24.6pp
FCF margin-259.9%+201pp

Returns & leverage

See full
Return on equity-6.1%-2.5pp
Debt / equity1.4×
Current ratio9.6×

Where this comes from

Reported directly by KEEL in its filing.

Tagged under the XBRL concept us-gaap:SaleOfStockConsiderationReceivedOnTransaction.

The official record: KEEL’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about KEEL's atm program issuances.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KEEL's ATM program issuances?
KEEL (KEEL) reported ATM program issuances of $31M in Q3 2025.
What does ATM program issuances mean?
Reflects the total cash proceeds generated from the issuance of common stock through At-The-Market (ATM) equity programs. This metric indicates the company's ability to raise capital by selling shares directly into the secondary market at prevailing prices. It is a key indicator of equity-based financing activity used to fund operations or expansion.